Updated: Important ENBREL Product Information

Update to U.S. Prescribing Information for ENBREL

Amgen and Wyeth are committed to the highest standards of patient safety.

The US Prescribing Information for ENBREL has been updated with the addition of a boxed warning relating to the risk of infections, including tuberculosis (TB), which is similar to labeling for other medicines in the TNF inhibitor class.

• Amgen and Wyeth Announce Update to US Prescribing Information for Enbrel^® (etanercept)
  
  
• Letter to Healthcare Professionals
  
  
• Prescribing Information for ENBREL